Value of 11 C-Choline PET/CT-Based Multi-Metabolic Parameter Combination in Distinguishing Early-Stage Prostate Cancer From Benign Prostate Diseases

The most common disadvantage of C-choline positron emission tomography and computed tomography (PET/CT) in diagnosing early-stage prostate cancer (PCa) is its poor sensitivity. In spite of many efforts, this imaging modality lacks the ideal parameter of choline metabolism for the diagnosis of PCa, a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in oncology 2020, Vol.10, p.600380
Hauptverfasser: Zhou, Shuoming, Fu, Hongliang, Liu, Changming, Zhu, Ziqiang, Zhang, Jiabin, Weng, Wubin, Kang, Jian, Liu, Qiang
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 600380
container_title Frontiers in oncology
container_volume 10
creator Zhou, Shuoming
Fu, Hongliang
Liu, Changming
Zhu, Ziqiang
Zhang, Jiabin
Weng, Wubin
Kang, Jian
Liu, Qiang
description The most common disadvantage of C-choline positron emission tomography and computed tomography (PET/CT) in diagnosing early-stage prostate cancer (PCa) is its poor sensitivity. In spite of many efforts, this imaging modality lacks the ideal parameter of choline metabolism for the diagnosis of PCa, and the single metabolic parameter, that is, maximal standardized uptake value (SUVmax), based on this imaging modality is insufficient. C-choline PET/CT-based multi-metabolic parameter combination can help break this limitation. Before surgery, SUVmax of choline, which is the most common metabolic parameter of C-choline PET/CT, mean standardized uptake value (SUVmean), prostate-to-muscle (P/M) ratio, metabolic tumor volume (MTV) and total lesion glycolysis (TLG) from 74 patients with histologically proven PCa were quantified. A total of 13 patients with focal chronic prostatitis without severe features and 30 patients with benign prostate hyperplasia were used for comparison. Univariable and multivariable analyses were performed to compare the patient characteristics and metabolic parameters of C-choline PET/CT. The performance of single parameters and the combination of parameters were assessed by using logistic regression models. The comparable c-statistics, which mean the area under the ROC curve in the logistic regression model, of SUVmax, SUVmean, and P/M ratio are 0.657, 0.667, and 0.672, respectively. The c-statistic significantly rose to 0.793 when SUVmax and SUVmean were combined with the P/M ratio. This parameter combination performed the best for PCa cases with all biochemical recurrence risks and for PCa patients grouped by different risk. The greatest improvement over a single parameter, such as P/M ratio, was noted in the group of low-risk PCa, with values of 0.535 to 0.772 for the three-parameter combination. And in the histopathological level, the Ki-67 index is positively correlated with the P/M ratio (r=0.491, =0.002). P/M ratio is a more ideal parameter than SUVmax as a single parameter in early-stage PCa diagnosis. According to our data, the combination of SUVmax, SUVmean, and P/M ratio as a composite parameter for diagnosis of early stage PCa improves the diagnostic accuracy of C-choline PET/CT.
doi_str_mv 10.3389/fonc.2020.600380
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_33598428</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>33598428</sourcerecordid><originalsourceid>FETCH-pubmed_primary_335984283</originalsourceid><addsrcrecordid>eNqFjzFPwzAQhS0EohV0Z0L3B5w6cVola00qlkqViBBbdUkvqVFiV7Yz9H_wg_EAohu3fCe99-70GHtKRSJlUS47a9okE5lI1kLIQtyweZbJnJe5_Li92mds4f2niLNeiVTIezaTclUWeVbM2dc7DhOB7SBNQXF1soM2BPuqXqqab9DTEXbTEDTfUcAmqi3s0eFIgRwoOzbaYNDWgDbwon3Qpp-0P0VAhW648LeAfTzorA8YCBSaNia3zo6wIaN786fFPMWP_pHddTh4WvzwgT1vq1q98vPUjHQ8nJ0e0V0OvzXkv4ZvwElb-w</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Value of 11 C-Choline PET/CT-Based Multi-Metabolic Parameter Combination in Distinguishing Early-Stage Prostate Cancer From Benign Prostate Diseases</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Zhou, Shuoming ; Fu, Hongliang ; Liu, Changming ; Zhu, Ziqiang ; Zhang, Jiabin ; Weng, Wubin ; Kang, Jian ; Liu, Qiang</creator><creatorcontrib>Zhou, Shuoming ; Fu, Hongliang ; Liu, Changming ; Zhu, Ziqiang ; Zhang, Jiabin ; Weng, Wubin ; Kang, Jian ; Liu, Qiang</creatorcontrib><description>The most common disadvantage of C-choline positron emission tomography and computed tomography (PET/CT) in diagnosing early-stage prostate cancer (PCa) is its poor sensitivity. In spite of many efforts, this imaging modality lacks the ideal parameter of choline metabolism for the diagnosis of PCa, and the single metabolic parameter, that is, maximal standardized uptake value (SUVmax), based on this imaging modality is insufficient. C-choline PET/CT-based multi-metabolic parameter combination can help break this limitation. Before surgery, SUVmax of choline, which is the most common metabolic parameter of C-choline PET/CT, mean standardized uptake value (SUVmean), prostate-to-muscle (P/M) ratio, metabolic tumor volume (MTV) and total lesion glycolysis (TLG) from 74 patients with histologically proven PCa were quantified. A total of 13 patients with focal chronic prostatitis without severe features and 30 patients with benign prostate hyperplasia were used for comparison. Univariable and multivariable analyses were performed to compare the patient characteristics and metabolic parameters of C-choline PET/CT. The performance of single parameters and the combination of parameters were assessed by using logistic regression models. The comparable c-statistics, which mean the area under the ROC curve in the logistic regression model, of SUVmax, SUVmean, and P/M ratio are 0.657, 0.667, and 0.672, respectively. The c-statistic significantly rose to 0.793 when SUVmax and SUVmean were combined with the P/M ratio. This parameter combination performed the best for PCa cases with all biochemical recurrence risks and for PCa patients grouped by different risk. The greatest improvement over a single parameter, such as P/M ratio, was noted in the group of low-risk PCa, with values of 0.535 to 0.772 for the three-parameter combination. And in the histopathological level, the Ki-67 index is positively correlated with the P/M ratio (r=0.491, =0.002). P/M ratio is a more ideal parameter than SUVmax as a single parameter in early-stage PCa diagnosis. According to our data, the combination of SUVmax, SUVmean, and P/M ratio as a composite parameter for diagnosis of early stage PCa improves the diagnostic accuracy of C-choline PET/CT.</description><identifier>ISSN: 2234-943X</identifier><identifier>EISSN: 2234-943X</identifier><identifier>DOI: 10.3389/fonc.2020.600380</identifier><identifier>PMID: 33598428</identifier><language>eng</language><publisher>Switzerland</publisher><ispartof>Frontiers in oncology, 2020, Vol.10, p.600380</ispartof><rights>Copyright © 2021 Zhou, Fu, Liu, Zhu, Zhang, Weng, Kang and Liu.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,861,4010,27904,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33598428$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhou, Shuoming</creatorcontrib><creatorcontrib>Fu, Hongliang</creatorcontrib><creatorcontrib>Liu, Changming</creatorcontrib><creatorcontrib>Zhu, Ziqiang</creatorcontrib><creatorcontrib>Zhang, Jiabin</creatorcontrib><creatorcontrib>Weng, Wubin</creatorcontrib><creatorcontrib>Kang, Jian</creatorcontrib><creatorcontrib>Liu, Qiang</creatorcontrib><title>Value of 11 C-Choline PET/CT-Based Multi-Metabolic Parameter Combination in Distinguishing Early-Stage Prostate Cancer From Benign Prostate Diseases</title><title>Frontiers in oncology</title><addtitle>Front Oncol</addtitle><description>The most common disadvantage of C-choline positron emission tomography and computed tomography (PET/CT) in diagnosing early-stage prostate cancer (PCa) is its poor sensitivity. In spite of many efforts, this imaging modality lacks the ideal parameter of choline metabolism for the diagnosis of PCa, and the single metabolic parameter, that is, maximal standardized uptake value (SUVmax), based on this imaging modality is insufficient. C-choline PET/CT-based multi-metabolic parameter combination can help break this limitation. Before surgery, SUVmax of choline, which is the most common metabolic parameter of C-choline PET/CT, mean standardized uptake value (SUVmean), prostate-to-muscle (P/M) ratio, metabolic tumor volume (MTV) and total lesion glycolysis (TLG) from 74 patients with histologically proven PCa were quantified. A total of 13 patients with focal chronic prostatitis without severe features and 30 patients with benign prostate hyperplasia were used for comparison. Univariable and multivariable analyses were performed to compare the patient characteristics and metabolic parameters of C-choline PET/CT. The performance of single parameters and the combination of parameters were assessed by using logistic regression models. The comparable c-statistics, which mean the area under the ROC curve in the logistic regression model, of SUVmax, SUVmean, and P/M ratio are 0.657, 0.667, and 0.672, respectively. The c-statistic significantly rose to 0.793 when SUVmax and SUVmean were combined with the P/M ratio. This parameter combination performed the best for PCa cases with all biochemical recurrence risks and for PCa patients grouped by different risk. The greatest improvement over a single parameter, such as P/M ratio, was noted in the group of low-risk PCa, with values of 0.535 to 0.772 for the three-parameter combination. And in the histopathological level, the Ki-67 index is positively correlated with the P/M ratio (r=0.491, =0.002). P/M ratio is a more ideal parameter than SUVmax as a single parameter in early-stage PCa diagnosis. According to our data, the combination of SUVmax, SUVmean, and P/M ratio as a composite parameter for diagnosis of early stage PCa improves the diagnostic accuracy of C-choline PET/CT.</description><issn>2234-943X</issn><issn>2234-943X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFjzFPwzAQhS0EohV0Z0L3B5w6cVola00qlkqViBBbdUkvqVFiV7Yz9H_wg_EAohu3fCe99-70GHtKRSJlUS47a9okE5lI1kLIQtyweZbJnJe5_Li92mds4f2niLNeiVTIezaTclUWeVbM2dc7DhOB7SBNQXF1soM2BPuqXqqab9DTEXbTEDTfUcAmqi3s0eFIgRwoOzbaYNDWgDbwon3Qpp-0P0VAhW648LeAfTzorA8YCBSaNia3zo6wIaN786fFPMWP_pHddTh4WvzwgT1vq1q98vPUjHQ8nJ0e0V0OvzXkv4ZvwElb-w</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Zhou, Shuoming</creator><creator>Fu, Hongliang</creator><creator>Liu, Changming</creator><creator>Zhu, Ziqiang</creator><creator>Zhang, Jiabin</creator><creator>Weng, Wubin</creator><creator>Kang, Jian</creator><creator>Liu, Qiang</creator><scope>NPM</scope></search><sort><creationdate>2020</creationdate><title>Value of 11 C-Choline PET/CT-Based Multi-Metabolic Parameter Combination in Distinguishing Early-Stage Prostate Cancer From Benign Prostate Diseases</title><author>Zhou, Shuoming ; Fu, Hongliang ; Liu, Changming ; Zhu, Ziqiang ; Zhang, Jiabin ; Weng, Wubin ; Kang, Jian ; Liu, Qiang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_335984283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhou, Shuoming</creatorcontrib><creatorcontrib>Fu, Hongliang</creatorcontrib><creatorcontrib>Liu, Changming</creatorcontrib><creatorcontrib>Zhu, Ziqiang</creatorcontrib><creatorcontrib>Zhang, Jiabin</creatorcontrib><creatorcontrib>Weng, Wubin</creatorcontrib><creatorcontrib>Kang, Jian</creatorcontrib><creatorcontrib>Liu, Qiang</creatorcontrib><collection>PubMed</collection><jtitle>Frontiers in oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhou, Shuoming</au><au>Fu, Hongliang</au><au>Liu, Changming</au><au>Zhu, Ziqiang</au><au>Zhang, Jiabin</au><au>Weng, Wubin</au><au>Kang, Jian</au><au>Liu, Qiang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Value of 11 C-Choline PET/CT-Based Multi-Metabolic Parameter Combination in Distinguishing Early-Stage Prostate Cancer From Benign Prostate Diseases</atitle><jtitle>Frontiers in oncology</jtitle><addtitle>Front Oncol</addtitle><date>2020</date><risdate>2020</risdate><volume>10</volume><spage>600380</spage><pages>600380-</pages><issn>2234-943X</issn><eissn>2234-943X</eissn><abstract>The most common disadvantage of C-choline positron emission tomography and computed tomography (PET/CT) in diagnosing early-stage prostate cancer (PCa) is its poor sensitivity. In spite of many efforts, this imaging modality lacks the ideal parameter of choline metabolism for the diagnosis of PCa, and the single metabolic parameter, that is, maximal standardized uptake value (SUVmax), based on this imaging modality is insufficient. C-choline PET/CT-based multi-metabolic parameter combination can help break this limitation. Before surgery, SUVmax of choline, which is the most common metabolic parameter of C-choline PET/CT, mean standardized uptake value (SUVmean), prostate-to-muscle (P/M) ratio, metabolic tumor volume (MTV) and total lesion glycolysis (TLG) from 74 patients with histologically proven PCa were quantified. A total of 13 patients with focal chronic prostatitis without severe features and 30 patients with benign prostate hyperplasia were used for comparison. Univariable and multivariable analyses were performed to compare the patient characteristics and metabolic parameters of C-choline PET/CT. The performance of single parameters and the combination of parameters were assessed by using logistic regression models. The comparable c-statistics, which mean the area under the ROC curve in the logistic regression model, of SUVmax, SUVmean, and P/M ratio are 0.657, 0.667, and 0.672, respectively. The c-statistic significantly rose to 0.793 when SUVmax and SUVmean were combined with the P/M ratio. This parameter combination performed the best for PCa cases with all biochemical recurrence risks and for PCa patients grouped by different risk. The greatest improvement over a single parameter, such as P/M ratio, was noted in the group of low-risk PCa, with values of 0.535 to 0.772 for the three-parameter combination. And in the histopathological level, the Ki-67 index is positively correlated with the P/M ratio (r=0.491, =0.002). P/M ratio is a more ideal parameter than SUVmax as a single parameter in early-stage PCa diagnosis. According to our data, the combination of SUVmax, SUVmean, and P/M ratio as a composite parameter for diagnosis of early stage PCa improves the diagnostic accuracy of C-choline PET/CT.</abstract><cop>Switzerland</cop><pmid>33598428</pmid><doi>10.3389/fonc.2020.600380</doi></addata></record>
fulltext fulltext
identifier ISSN: 2234-943X
ispartof Frontiers in oncology, 2020, Vol.10, p.600380
issn 2234-943X
2234-943X
language eng
recordid cdi_pubmed_primary_33598428
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; PubMed Central; Alma/SFX Local Collection
title Value of 11 C-Choline PET/CT-Based Multi-Metabolic Parameter Combination in Distinguishing Early-Stage Prostate Cancer From Benign Prostate Diseases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T06%3A11%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Value%20of%2011%20C-Choline%20PET/CT-Based%20Multi-Metabolic%20Parameter%20Combination%20in%20Distinguishing%20Early-Stage%20Prostate%20Cancer%20From%20Benign%20Prostate%20Diseases&rft.jtitle=Frontiers%20in%20oncology&rft.au=Zhou,%20Shuoming&rft.date=2020&rft.volume=10&rft.spage=600380&rft.pages=600380-&rft.issn=2234-943X&rft.eissn=2234-943X&rft_id=info:doi/10.3389/fonc.2020.600380&rft_dat=%3Cpubmed%3E33598428%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/33598428&rfr_iscdi=true